LEP and breast carcinoma: Leptin being a pleiotropic adipokine has been shown to cause activation of various signaling pathways leading to tumor growth/cell proliferation, such as via up regulation of angiogenesis in breast cancer [58], or suppression of apoptosis in colon cancer cells [59], and hepatic cancer cells [7].